Public Consultation on the Post Market Review of Products Used in the Management of Diabetes on Stage One: Blood Glucose Test Strips
Page last updated: 19 December 2012
Stakeholder Forum Outcomes
The Stakeholder Forum was held in Canberra on 19 November 2012 for Stage One regarding Blood Glucose Test Strips.
The Forum provided a further opportunity for stakeholders to contribute to Stage One of the Review. The Forum summary is now available for viewing:
The Call for Submissions closed on 15 November 2012. The Department appreciates the contribution of all organisations and individuals who made a submission.
Unless otherwise requested, submissions addressing Terms of Reference 5 to 7 have been published below. This Stage of the Review focussed on the utilisation and patterns of use of self-monitoring of blood glucose (SMBG) and the clinical outcomes and benefits of SMBG for people with type 2 diabetes not treated with insulin.
Some of the contents of these submissions may have been included in the draft Report. Submissions, or parts thereof, that are intended to remain confidential should have been clearly marked as such and justifications provided. The Department of Health and Ageing has not published submissions, or parts of submissions, which contain personal information, offensive language, potentially defamatory material or copyright infringing material.
Responsibility for copyright in submissions resides with the author(s), not with the Department of Health and Ageing.
All submissions have been converted to Portable Document Format (PDF) for publication and may have a different appearance to the document that was submitted.
More information is available at Post Market Review of Products Used in the Management of Diabetes. If you have difficulty accessing the information provided and need further assistance, please send an email to PBSpostmarket@health.gov.au
- The views expressed in submissions published on this website are solely those of the contributing authors or organisations.
- The Commonwealth accepts no responsibility for the completeness or accuracy of any information contained in the submissions.
- The Commonwealth makes no representations about the suitability of the information for any particular purpose. Users of the information must make their own inquires and assessments about those matters or seek independent advice.
- Submissions are published on the understanding that the contributing authors or organisations have copyright in the submissions either by way of ownership or a licence. They retain their copyright, and by making submissions they licence the Commonwealth to publish the submissions, unless a party when making a submission has requested that it be kept confidential and the Commonwealth clearly agrees that the submission will be kept confidential.
- The Commonwealth reserves the right not to publish a submission or part of a submission that it considers defamatory or otherwise inappropriate for publication.
Table of Submissions
|Submission||Author Name||Document link||Date Received|
|1||Michael Porter Sugarman||Submission 1 (PDF 125KB)||31/10/2012|
|2||Australian Medical Association||Submission 2 (PDF 79KB)||13/11/2012|
|3||Consumer||Not for publication||13/11/2012|
|4||Roche Diagnostics Australia Pty Limited||Submission 4 (PDF 971KB)||13/11/2012|
|5||AIHW||Submission 5 (PDF 299KB)||14/11/2012|
|6||Royal Australian College of General Practitioners||Submission 6 (PDF 234KB)||14/11/2012|
|7||Professor Stephen Colagiuri||Submission 7 (PDF 376KB)||14/11/2012|
|8||Consumers Health Forum of Australia||Submission 8 (PDF 301KB)||14/11/2012|
|9||NPS -Medicine Wise||Submission 9 (PDF 416KB)||14/11/2012|
|10||Bermaci Consulting||Submission 10 (PDF 464KB)||14/11/2012|
|11||Medical Technology Association of Australia||Submission 11 (PDF 193KB)||15/11/2012|
|12||Medical Specialities Australia||Submission 12 (PDF 17KB)||14/11/2012|
|13||Sanofi||Submission 13 (PDF 30KB)||15/11/2012|
|14||IVD Australia||Submission 14 (PDF 757KB)||15/11/2012|
|15||Diabetes Association of the NT, Healthy Living||Submission 15 (PDF 219KB)||15/11/2012|
|16||Boehringer Ingelheim||Submission 16 (PDF 281KB)||15/11/2012|
|17||Pharmaceutical Society of Australia||Submission 17 (PDF 98KB)||15/11/2012|
|18||Professional Peak Body||Not for publication||15/11/2012|
|19||Australian College Nursing||Submission 19 (PDF 298KB)||15/11/2012|
|20||Royal College of Pathologists Australasia||Submission 20 (PDF 34KB)||15/11/2012|
|21||Medicines Australia||Submission 21 (PDF 191KB)||15/11/2012|
|22||Dietitians Association of Australia||Submission 22 (PDF 200KB)||15/11/2012|
|23||Martin's Chemist||Submission 23 (PDF 165KB)||15/11/2012|
|24||Diabetes Australia||Submission 24 (PDF 844KB)||15/11/2012|
|25||Australian Centre for Behavioural Research in Diabetes||Submission 25 (PDF 840KB)||15/11/2012|
|26||AstraZeneca and Bristol-Meyers Squibb||Submission 26 (PDF 40KB)||15/11/2012|
|27||Abbott Australasia Trading as Abbott Diabetes Care||Not for publication||15/11/2012|
|28||Industry Organisation||Not for publication||15/11/2012|
|29||Australian Diabetes Council||Submission 29 (PDF 313KB)||15/11/2012|
|30||Australian Diabetes Educators Association||Submission 30 (PDF 308KB)||15/11/2012|
|31||Pharmacy Guild of Australia||Submission 31 (PDF 928KB)||15/11/2012|
|32||Royal Australasian College of Physicians||Submission 32 (PDF 89KB)||22/11/2012|
|33||Diabetes WA||Submission 33 (PDF 685KB)||22/11/2012|